Very Rare: Nervousness, restlessness, euphoria, confusion, tinnitus, somnolence, blurred or double vision, chill, tremor, loss of consciousness. Nervous System Disorders: Uncommon: Dyschezia, hypoesthesia. İmmune System Disorders: Very Rare: Allergic reactions (anaphylactic shock may be seen in severe events). The frequency classification of adverse effects are listed as following: Very common (≥1/10) common (≥1/100 to <1/10) uncommon (≥1/1,000 to <1/100) rare (≥1/10,000 to <1/1,000) very rare (<1/10,000), not known (cannot be estimated from the available data). In clinical studies, the majority of adverse effects are local reactions at the application area eg, mild or moderate local irritation, erythema, rash, desquamation, pruritus. Sulidin Thermo: Adverse effects possibly related to local treatment have been infrequently reported. However, when Ul-flam is applied long-term and in high doses, the occurrence of systemic adverse effects should not be neglected. When Ul-flam is applied topically, the possibility of occurrence of systemic adverse effects is less in comparison to oral administration. Not Known: Desquamation, pruritus, rash, mild or moderate local irritation.
#Flam tab notes skin
Skin and Subcutaneous Tissue Disorders: Uncommon: Pruritus, erythema.
The frequency of adverse events listed as follows is defined using the following convention: Very common (≥1/10) common (≥1/100 to <1/10) uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000) very rare (<1/10,000), not known (cannot be estimated from the available data). In clinical trials, the majority of adverse effects are local reactions at the application site eg, mild or moderate local irritation, erythema, rash, desquamation, pruritus. Ul-flam: Adverse effects possibly related to local treatment have been infrequently reported.
Gel: No clinically significant interactions involving interference with drug metabolism have been reported with topical application of Ul-flam. Clinically important interactions involving interference with drug metabolism have not been described with Ul-flam.
0 kommentar(er)
